![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Animal and Dairy Science Department,
*
Physiology and Pharmacology Department, The University of Georgia, Athens, GA 30602 and
U.S. Department of Agriculture, ARS, R. Russel Research Center, Athens, GA 30602
2To whom correspondence should be addressed. E-mail: markf{at}arches.uga.edu.
This study was undertaken to determine whether casein, compared with its constituent amino acids, given at the onset of a meal, would influence intake due to cholecystokinin (CCK) or opioid activity. Male Sprague-Dawley rats (n = 80; 225 g) were given either premeal loads of casein or its constituent amino acids and treated with opioid or CCK antagonists in a 2 x 4 factorially designed experiment. During a 21-d period, rats were meal-fed by restricting access to food to 5 h/d. The rats were fed the AIN-93 diet with soy isolate substituted for casein as the dietary protein source. On d 7–21, rats were given oral premeal loads of 5 mL of a 50 g/L casein or constituent amino acid solution before meal-feeding. On d 14–21, 20 rats were injected intraperitoneally with one of the following treatments: saline, naltrexone (l mg/kg), naloxone methiodide (5 mg/kg) or lorglumide (1 mg/kg) before the premeal load and feeding. Antagonist treatments increased intake (P < 0.05) by 15.3% compared with saline treatment (7.82 vs. 9.02 g/d) in rats given premeal loads of casein. Intake of rats given premeal loads of amino acids was not influenced by antagonists. At 2 h after feeding on d 21, the rats were killed, bled and eviscerated. Effects of antagonists on stomach and intestinal mass, digesta contents and fecal output were also dependent on the type of premeal load, indicating that gastric retention of digesta due to casein was mediated by CCK and opioids. Body weight accretion, liver, and epididymal fat mass and blood concentrations of specific amino acids changed in the same manner as intake (P < 0.05). Serum insulin was greater (P < 0.05) in casein-treated rats and reduced (P < 0.01) by opioid antagonists. Satiety associated with premeal loads of casein is related to changes in gastrointestinal function of meal-fed animals and involves both opioid and CCK regulation.
KEY WORDS: • intake • satiety • casein • opioids • cholecystokinin • rats
This article has been cited by other articles:
|
|
 |
|
  B. L. Luhovyy, T. Akhavan, and G. H. Anderson Whey Proteins in the Regulation of Food Intake and Satiety J. Am. Coll. Nutr., December 1, 2007; 26(6): 704S - 712S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Aziz, G. H. Anderson, A. Giacca, and F. Cho Hyperglycemia after protein ingestion concurrent with injection of a GLP-1 receptor agonist in rats: a possible role for dietary peptides Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2005; 289(3): R688 - R694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. H. Anderson and S. E. Moore Dietary Proteins in the Regulation of Food Intake and Body Weight in Humans J. Nutr., April 1, 2004; 134(4): 974S - 979S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Lin, S. R. Thomas, G. Kilroy, G. J. Schwartz, and D. A. York Enterostatin inhibition of dietary fat intake is dependent on CCK-A receptors Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R321 - R328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Aziz and G. H. Anderson Exendin-4, a GLP-1 Receptor Agonist, Interacts with Proteins and Their Products of Digestion to Suppress Food Intake in Rats J. Nutr., July 1, 2003; 133(7): 2326 - 2330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Pupovac and G. H. Anderson Dietary Peptides Induce Satiety via Cholecystokinin-A and Peripheral Opioid Receptors in Rats J. Nutr., September 1, 2002; 132(9): 2775 - 2780. [Abstract] [Full Text] [PDF]
|
|
